Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2018-08-01
2033-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Arthroscopic Scapholunate Ligament Reconstruction
NCT06236204
Evaluation of the Long-term Outcome of Dorsal Ligamentoplasty Reinforced With an Internal Brace in the Treatment of Scapholunate Instability
NCT06493318
Scapholunate Ligament Partial Tears; Tear Localization, Extrinsic Ligament Injury Association and Conservative Treatment Responses Prior to Instability
NCT05102357
Comparison Between Abduction External Rotation Brace and Arm Sling After Arthroscopic Rotator Cuff
NCT05948995
Evaluation of the Surgical Proficiency and Effectiveness of the Acumed Scapholunate Repair System in Primary Scapholunate Instability Among Canadians
NCT04980547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Berger
Bergers capsulodesis
Berger
Treatment 1
3LT
Three ligament tenodesis
3LT
Treatment 2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Berger
Treatment 1
3LT
Treatment 2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptomatic SL instability (VAS score ³3, QDASH score ³ 20).
* \> 6 weeks since symptomatic hand trauma (chronic SL lesions).
* SL gapping on radiographic stress views or SL gapping (³2mm) on static PA views.
* Complete SL ligament lesion confirmed by wrist arthroscopy
Exclusion Criteria
* Concomitant complete luno-triquetral (LT) ligament injury (evaluated by arthroscopy).
* Lesion of TFCC leading to DRUJ instability (evaluated by arthroscopy).
* Radiocarpal or midcarpal arthritis evaluated by arthroscopy.
* Previous fracture in carpus or intraarticular radius fracture with step off (³2 mm), disposing to posttraumatic arthritis.
* Adverse effects after extra articular radial fractures (dorsal angulation ³10 grader).
* Peroperatively non-reducible scaphoid flexion/SL gap.
* Terminal illness or severe medical illness: ASA score higher than or equal to 3.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janni K Thillemann, Dr
Role: PRINCIPAL_INVESTIGATOR
Hospitalsenheden Vest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, , Denmark
Hospital Unit Vest
Holstebro, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Maiken Stilling, Professor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-169-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.